Viridian Therapeutics, Inc. (VRDN)

28.94 -0.46 (-1.56%) USD  |  NASDAQ  |  Feb 25, 16:00
28.84 -0.10 (-0.35%) After-Hours: 04:07
More

Viridian Therapeutics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for VRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Avantor, Inc. Upgrade
Immunovant, Inc. --
Plus Therapeutics, Inc. Upgrade